Biologics

How Do Children With IBD and Their Caregivers Perceive Biosimilars?
How Do Children With IBD and Their Caregivers Perceive Biosimilars? 1024 683 JoAnna Pendergrass, DVM

Many pediatric patients with inflammatory bowel disease and their caregivers are unaware of biosimilars, creating an opportunity for providers to educate patients and their families about this effective and less expensive treatment option. Infliximab is a biologic therapy that effectively manages inflammatory bowel disease (IBD) in adult and pediatric patients. However, biologic therapies are expensive,…

read more